$Absci(ABSI.US) | ๐๐๐ฌ๐๐ข: H.C. Wainwright reiterates ๐๐ฎ๐ฒ, maintains ๐๐ ๐๐ญ $๐
Analyst sees potential for best-in-class hair loss therapy, with ABS-201 efficacy benchmark positioning as key upside driver.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments